Clinical Trial Update: Long Term Follow up Study of Long-acting hGH (MOD-4023) in Growth Hormone Deficient Children [Phase 2]

View source ↗

Summary

Phase 2 long-term follow-up study of MOD-4023, a long-acting growth hormone, in children with growth hormone deficiency has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• MOD-4023 (long-acting growth hormone)

Snippet

Sponsor: OPKO Health, Inc. | Conditions: Growth Hormone Deficiency (GHD) | Phase 2 | Status: COMPLETED | Results posted: 2025-04-09